Two existing medications work effectively together in treating alcohol use disorder
Two existing medications - one used for smoking cessation and the other for depression - appear to work effectively together in treating alcohol use disorder.
Machine learning identifies key lifestyle factors for healthy brain function
A new study offers insight into the health and lifestyle indicators - including diet, physical activity and weight - that align most closely with healthy brain function across the lifespan.
Nanoneedle patch could replace painful traditional biopsies
A patch containing tens of millions of microscopic nanoneedles could soon replace traditional biopsies, scientists have found.
Video consultations match physical visits for surgical preparation
A video consultation between patient and surgeon is just as good as a physical visit to the outpatient clinic to discuss a major operation.
Loneliness not linked to increased death risk in older adults
Various reports have linked loneliness to premature death, with some - including the U.S. Surgeon General - suggesting that loneliness is as harmful to one's health as smoking 15 cigarettes…
How funding influences cardiac red meat study conclusions
A review reveals how industry funding influences red meat studies, highlighting the need for transparent nutrition research on cardiovascular health impacts.
A revolutionary drug for extreme hunger offers clues to obesity’s complexity
Ali Foley Shenk still remembers the panic when her 10-year-old son, Dean, finished a 20-ounce box of raisins in the seconds the cupboard was left unlocked. They rushed to the…
‘Not accountable to anyone’: As insurers issue denials, some patients run out of options
By the time Eric Tennant was diagnosed in 2023 with a rare cancer of the bile ducts, the disease had spread to his bones. He weighed 97 pounds and wasn't…
Statins could reduce breast cancer mortality by a fifth
Research indicates statins could enhance breast cancer prognosis, with lipophilic statins showing greater protective effects against mortality and recurrence.
FDA approval of pembrolizumab marks major shift in head and neck cancer treatment
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous cell…